|
John was Managing Director and previously CEO of GroPep Ltd until 2002, positions he held since the inception of the company in 1988. From 1991 until 1999 he was also the CEO of the Cooperative Research Centre for Tissue Growth and Repair in which GroPep was a partner. He was the foundation Chairman of PrimeGRO Ltd from 1999 until 2002 and is currently a Director of Australian Orthopaedic Innovations Pty Ltd and Vice President of AusBiotech Ltd, the Australian biotechnology industry association. He is a biochemist by training (PhD, DSc), has authored more than 300 research publications and is an inventor of 10 patents. He was elected to the Australian Academy of Technological Sciences and Engineering in 1997.
P. John Gorman Chief Financial Officer - Macquarie University
John was appointed to the position of Chief Financial Officer in September 2007. For the 4 ½ years prior to that John was the Chief Financial Officer for WSN Environmental Solutions, a NSW State Owned Corporation Operating in the waste management industry. Prior to that, John has held the position of Chief Financial Officer and, in some instances, Company Secretary, for several publicly-listed entities in industries involved in manufacturing, transport and logistics. In the 20 years prior to this, he held senior finance positions in the oil industry, in sectors ranging from refining and distribution to exploration and development.
His strengths are in the areas of capital raising and debt structure, investment management, financial and management reporting and organisational change. John is responsible for all financial matters pertaining to the organisation and is a member of the University Executive.
Mark is a biochemist with 14 years experience in proteomics, specialising in separation sciences and quantitative mass spectrometry. He has strong interests in biomedical applications, in particular molecular cancer biology, and is developing methods to quantitatively profile changes in protein phosphorylation.
Mark conducted PhD research with Prof. Keith Williams in the fledgling APAF facility, and then went on to post-doctoral research with Prof. Philip Andrews in the Dept. Biological Chemistry at the University of Michigan Medical School.
Mark was employed as a Senior Principal Scientist at Pfizer Inc, in Ann Arbor, USA leading a team to identify biomarkers of new drug entities. He returned to APAF in 2004 to direct biomedical research projects.
Mark is an NHMRC RD Wright fellow undertaking research to identify prognostic and predictive colorectal cancer biomarkers. As facility Director he oversees the operations of APAF.
Jim Piper was appointed DVC(R) at Macquarie University in Sydney in 2003. He was formerly the Dean of Division of Information and Communication Sciences at Macquarie University from 1997 to 2002; and previously Professor of Physics at Macquarie from 1984.
Professor Piper graduated from the University of Otago, New Zealand with a BSc Honours in Physics. He remained at the University of Otago for his doctoral research and was subsequently awarded a DPhil in Physics.
In 1971 Professor Piper accepted a Research Fellowship at Oxford University for four years before moving to Australia and taking up a position at Macquarie University as Senior Lecturer and Associate Professor in Physics.
Throughout his career, Professor Piper has received many distinguished awards including the Pawsey Medal (1982), the Australian Optical Society Medal (1997) and more recently was awarded the Carnegie Centenary Professorship from the Carnegie Trust Universities of Scotland (2004).
Professor Piper has extensive expertise and experience gained from over 30 years of research in lasers, optics and photonics, and applications in micro fabrication.
|